INCY

Incyte Corporation (INCY)

Last Price$71.9(0.7%)
Market Cap$13.9B
LTM P/E
426.6x
EPS growth
49.2%
PEGY
8.7x
Peter Lynch Fair Value
$8.3
Overvalued (Peter Lynch formula)
(88.5%)
Stock quality
5/10
Good

INCY Peter Lynch Fair Value

Peter Lynch Fair Value Assumptions

as of Jan 26, 2025
LTM P/E
426.6x
EPS growth
49.2%
Dividend Yield
0.0%
PEGY
8.7x
Last share price
$71.9
Peter Lynch Fair Value
$8.3
88.5% overvalued

Peter Lynch Fair Value Calculation

PEGY
8.7x
=
LTM P/E
426.6x
/
(
EPS growth
49.16%
+
Dividend yield
0.00%
)
Peter Lynch
Fair Value
$8.3
=
Last share price
$71.9
/
PEGY
8.7x

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

INCY EPS growth & Dividend Yield

Crunching data... Almost there!

INCY vs Peer Set: Peter Lynch Fair Value Comparison

Crunching data... Almost there!

Explore more intrinsic value tools hub for INCY

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

What is Incyte Corporation fair value by Peter Lynch formula?

As of Jan 17, 2025, Incyte Corporation's fair value using the Peter Lynch formula is $8.3 per share. The current price of $71.9 suggests Incyte Corporation may be overvalued by this metric.

What is Incyte Corporation Price to Earnings (P/E) ratio?

As of Jan 17, 2025, Incyte Corporation's P/E ratio is 426.6x. This is calculated by dividing the current share price of $71.9 by the Earnings per Share (EPS) for the trailing twelve months, which is $0.2. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.

What is Incyte Corporation earnings per share (EPS)?

Incyte Corporation earnings per share (EPS) for the twelve months ending Jan 17, 2025, was $0.2, a 49.2% growth year-over-year.